[go: up one dir, main page]

FI20055653L - Leimausreagenssi - Google Patents

Leimausreagenssi Download PDF

Info

Publication number
FI20055653L
FI20055653L FI20055653A FI20055653A FI20055653L FI 20055653 L FI20055653 L FI 20055653L FI 20055653 A FI20055653 A FI 20055653A FI 20055653 A FI20055653 A FI 20055653A FI 20055653 L FI20055653 L FI 20055653L
Authority
FI
Finland
Prior art keywords
labeling
derivatives
dtpa
reactants
labeling reagent
Prior art date
Application number
FI20055653A
Other languages
English (en)
Swedish (sv)
Other versions
FI20055653A0 (fi
FI20055653A7 (fi
Inventor
Jari Hovinen
Jari Peuralahti
Veli-Matti Mukkala
Original Assignee
Wallac Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallac Oy filed Critical Wallac Oy
Priority to FI20055653A priority Critical patent/FI20055653A7/fi
Publication of FI20055653A0 publication Critical patent/FI20055653A0/fi
Priority to FI20060485U priority patent/FI7472U1/fi
Priority to US11/607,045 priority patent/US7381420B2/en
Priority to PCT/FI2006/050538 priority patent/WO2007065973A1/en
Publication of FI20055653L publication Critical patent/FI20055653L/fi
Publication of FI20055653A7 publication Critical patent/FI20055653A7/fi
Priority to US12/054,871 priority patent/US20080176338A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13Labelling of peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI20055653A 2005-12-08 2005-12-08 Leimausreagenssi FI20055653A7 (fi)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI20055653A FI20055653A7 (fi) 2005-12-08 2005-12-08 Leimausreagenssi
FI20060485U FI7472U1 (fi) 2005-12-08 2006-11-27 Leimausreagenssi
US11/607,045 US7381420B2 (en) 2005-12-08 2006-12-01 Labeling reactant
PCT/FI2006/050538 WO2007065973A1 (en) 2005-12-08 2006-12-05 Labeling reactants suitable for solid-phase synthesis
US12/054,871 US20080176338A1 (en) 2005-12-08 2008-03-25 Labeling reactant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20055653A FI20055653A7 (fi) 2005-12-08 2005-12-08 Leimausreagenssi

Publications (3)

Publication Number Publication Date
FI20055653A0 FI20055653A0 (fi) 2005-12-08
FI20055653L true FI20055653L (fi) 2007-06-09
FI20055653A7 FI20055653A7 (fi) 2007-06-09

Family

ID=35510731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20055653A FI20055653A7 (fi) 2005-12-08 2005-12-08 Leimausreagenssi

Country Status (3)

Country Link
US (2) US7381420B2 (fi)
FI (1) FI20055653A7 (fi)
WO (1) WO2007065973A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20055653A7 (fi) * 2005-12-08 2007-06-09 Wallac Oy Leimausreagenssi

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831175A (en) 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5693309A (en) 1987-03-31 1997-12-02 Schering Aktiengesellschaft Substituted complexing agents, complexes, and complex salts, processes for their production, and pharmaceuticals containing same
US5637759A (en) * 1992-07-30 1997-06-10 The Regents Of The University Of California Metal-ligating amino acid derivatives for MRI and for peptide synthesis
US5650134A (en) 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
DE4341724A1 (de) 1993-12-03 1995-06-08 Schering Ag Halogenaryl-substituierte Metallkomplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
AU734827B2 (en) * 1997-05-21 2001-06-21 Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
IL125314A (en) * 1998-07-12 2004-07-25 Peptor Ltd Processes for attaching amino acids using a bite - (trichloromethyl) carbonate
TWI284539B (en) 2001-07-30 2007-08-01 Epix Pharm Inc A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
US7303741B2 (en) 2002-09-23 2007-12-04 General Electric Company Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism
FI20055653A7 (fi) * 2005-12-08 2007-06-09 Wallac Oy Leimausreagenssi

Also Published As

Publication number Publication date
US20070134162A1 (en) 2007-06-14
US20080176338A1 (en) 2008-07-24
US7381420B2 (en) 2008-06-03
FI20055653A0 (fi) 2005-12-08
FI20055653A7 (fi) 2007-06-09
WO2007065973A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
DK1539948T3 (da) Forbedrede metoder til in vitro proteinsyntese
CY1112053T1 (el) Συνθεση ενωσεων βορονικων εστερων και οξεων
BRPI0413309A (pt) vacinas conjugadas de polissacarida -proteìna
Sasmal et al. Transition metals and transition metals/lewis acid cooperative catalysis for directing group assisted para-C–H functionalization
Raynal et al. Photochemical methods for peptide macrocyclisation
Yousif et al. Katritzky Salts for the Synthesis of Unnatural Amino Acids and Late‐Stage Functionalization of Peptides
Xu et al. Hydrogen‐Bonding‐Mediated Dynamic Covalent Synthesis of Macrocycles and Capsules: New Receptors for Aliphatic Ammonium Ions and the Formation of Pseudo [3] rotaxanes
Huang et al. N‐Phenyl‐N‐aceto‐vinylsulfonamides as Efficient and Chemoselective Handles for N‐Terminal Modification of Peptides and Proteins
WO2018234483A1 (en) Tunable probes for selective protein labelling and enzyme inhibition
Voss et al. α‐Keto phenylamides as P1′‐extended proteasome inhibitors
Song et al. Fe‐Catalyzed Aliphatic C− H Methylation of Glycine Derivatives and Peptides
Nienałtowski et al. Large‐Scale Synthesis of a Niche Olefin Metathesis Catalyst Bearing an Unsymmetrical N‐Heterocyclic Carbene (NHC) Ligand and its Application in a Green Pharmaceutical Context
FI20055653L (fi) Leimausreagenssi
CN103408573B (zh) 硼酸衍生物及其制备方法和应用
Dardir et al. Palladium-catalyzed Suzuki–Miyaura reactions of aspartic acid derived phenyl esters
Zhou et al. Chiral polyamines from reduction of polypeptides: asymmetric pyridoxamine-mediated transaminations
CN103408572B (zh) 手性氨基硼酸衍生物及其制备方法和应用
EP1456227A4 (en) ISOTOPE-MARKED AND NON-AFFINITY-BASED PEPTIDES AND METHODS OF USE THEREOF
Chen et al. Metal-free direct amidation of peptidyl thiol esters with α-amino acid esters
Gauchot et al. Catalytic anions embedded into avidin: importance of their chirality and the chiral environment on the stereocontrol of the aldol reaction
Lim et al. Recent Advances in Transition Metal‐Catalyzed Multideuteration of (Hetero) Arenes via Hydrogen Isotope Exchange
WO2006079099A3 (en) Method of conjugating aminothiol containing molecules to a polymer
SE9904222L (sv) Nya funktionaliserade polymera reagens
EP4364732A3 (en) Functionalized isonitriles and products, preparation and uses thereof
Vasantha et al. Synthesis of novel glycopeptidomimetics via Nβ-protected-amino alkyl isonitrile based Ugi 4C reaction